ADVI Will Be Presenting at ISPOR 2024

ADVI Health experts will be presenting at ISPOR’s Annual Conference from May 5-8, 2024 in Atlanta, Georgia. ADVI experts Caitlin Sheetz, solution leader for the Strategic Analytics, and Value Economics (SAVEs) team, Peter Kardel, chief data scientist, and David Liu, data analyst will be presenting four poster presentations at the event including:

  • Characteristics of Medicare Beneficiaries with Multiple Administrations of CAR-T Therapy
  • CMS Coverage Lift on Pet Beta Amyloid Imaging Impact on Mab Treatment and Beneficiary Out-of-pocket Spending
  • Navigating the Currents of the Pandemic: A Comprehensive Analysis of Medicare Data Reflecting COVID-19’s Impact on Cardiovascular Disease Healthcare Utilization
  • Evaluating Healthcare Costs and Demographics of Medicare Part D Beneficiaries Impacted By First Top 10 Drugs Selected for Price Negotiations Under the Inflation Reduction Act (IRA). This poster was selected for a poster tour, which will include a three-minute presentation and a five-minute Q&A session. This study was also selected as a Top 5 Percent Finalist and eligible for the ISPOR 2024 Research Presentation Awards, which will be awarded at the conference.

Ben Shand, head of business development, will also be onsite to meet with those interested in learning more.

Want to meet with us at the event? Click Get in Touch to book a time that works for your schedule.

 

You can view the poster presentations here:

ADVI Team

Caitlin Sheetz

Solution Leader, SAVEs

Peter Kardel

Chief Data Scientist

Ben Shand

Head of Business Development

David Liu

Data Analyst

Further Resources:

ADVI insights

Insights,

| Allison Schneider - Senior Manager

ADVI Analysis: MedPAC October 2024 Meeting

Insights,

| Lindsay Bealor Greenleaf, JD, MBA - Solution Leader, Federal and State Policy

ADVI Instant: CMS Finalizes Guidance on IPAY 2027 Negotiation and MFP Implementation for 2026/27

Insights,

| Lindsay Bealor Greenleaf, JD, MBA - Solution Leader, Federal and State Policy

ADVI Instant: CMS Releases Medicaid Drug Rebate Program Final Rule